Clinical trials
Infertile Females or Females With Ovarian Insufficiency clinical trials
Below are recruiting infertile females or females with ovarian insufficiency clinical trials, each written for real people, not researchers. We’re tracking 166 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06377917Recruiting
Testing timing of assisted hatching in IVF
This study compares two different timings for a lab procedure called assisted hatching (making a small opening in the embryo's outer shell) to see if one helps more embryos implant. You may be eligible if you're doing IVF with a frozen embryo transfer of a single screened embryo.
Marlton, New JerseyAges 18–42 - NCT07087171Recruiting
AI tool for patient engagement in fertility treatment
This trial tests a new AI tool designed to help patients actively participate in their own fertility care. It may benefit people starting or considering medically assisted reproduction treatments like IVF or artificial insemination.
LisbonAges 18–45 - NCT06629766Recruiting
Study on how father's age affects embryo growth
This study looks at how the father's age might affect the growth of embryos in the lab. It is for couples doing their first IVF cycle, planning to test embryos for genetic health before freezing them, and then transferring one healthy embryo.
Basking Ridge, New JerseyAges 18–41 - NCT06518928Recruiting
AI sperm selection for IVF with ICSI
This trial tests an artificial intelligence system that helps select the best sperm for use during IVF with ICSI. The goal is to see if this improves fertilization, embryo development, and reduces early pregnancy loss.
Las Vegas, NevadaAges Any age - NCT05080569RecruitingPhase 4
Extra support after IUI for couples with unclear infertility
This study tests whether adding support in the period after ovulation (the “luteal phase”) helps people who are starting IUI (intrauterine insemination) because their infertility is unexplained. It’s designed to see if the added care improves chances when mild ovarian stimulation is used.
UtrechtAges 18 years+ - NCT04602377RecruitingPhase 2
Pembrolizumab with standard chemo for ovarian small cell cancer
This Phase 2 trial tests whether adding pembrolizumab (an immune medicine) to standard chemotherapy can improve outcomes for people with small cell cancer of the ovary that has not been treated before. It may help your immune system recognize and attack the cancer while you receive chemotherapy.
AngersAges 12 years+ - NCT04619524Recruiting
Blood and lining tests during IVF cycles to guide endometrial timing
This study looks at “biomarkers” (test signals in your blood or cycle data) to better judge how ready the womb lining is during IVF. It compares two types of IVF hormone setups to see which approach best matches endometrial receptivity and supports successful embryo transfer.
Brno, South MoravianAges Up to 36 years - NCT04255615Recruiting
AI tool to improve IVF and embryo freezing assessments
This study uses an artificial intelligence (computer) tool to look at results from IVF and related fertility treatments. It may help clinicians assess outcomes more accurately for people going through ovarian stimulation and embryo or egg freezing.
New York, New YorkAges 18–89 - NCT06358547Recruiting
Genetic testing of embryos for women aged 37-41
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
København ØAges 18–41 - NCT06122207Recruiting
Probiotic for women with fertility issues and IVF
This study tests whether a probiotic (a pill with beneficial bacteria) can help improve the health of the female genital tract for people with fertility problems who are undergoing IVF. It aims to see if this can improve chances of pregnancy.
LisbonAges 18–45 - NCT06581068Recruiting
Automated IVF lab study for better fertility outcomes
This study tests a new automated system for IVF lab procedures to see if it improves success rates. Patients with specific fertility needs may join if they meet health and age requirements.
Mexico City, Mexico CityAges 18–45 - NCT06144268Recruiting
Sperm selection for intrauterine insemination
This trial tests a device called ZyMōt Multi that selects the best sperm for intrauterine insemination (IUI). It may help couples trying to conceive by improving the chance of a live birth.
BrusselsAges 18–36 - NCT07696351RecruitingPhase 4
Ultrasound-guided endometrial preparation for endometriosis
This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.
Nanjing, JiangsuAges 18–39 - NCT06304792Recruiting
Immediate vs. later frozen embryo transfer in women with regular or irregular cycles
This trial compares transferring a frozen embryo right away versus waiting for a later cycle. It is designed for women with regular or irregular menstrual cycles who have at least one good-quality frozen embryo.
CopenhagenAges 18–40 - NCT04163133Recruiting
Timing changes during ovarian stimulation for IVF
This study tests whether changing the timing of hormones during ovarian stimulation can improve IVF results for people with certain ovarian reserve levels. It may help find a stimulation approach that works better for first-time (or second) IVF cycles.
Beijing, Beijing MunicipalityAges 18–42 - NCT07148999RecruitingPhase 1/Phase 2
Personalized IVF decision support tool
This trial is testing a new computer tool to help personalize IVF treatment for women with infertility. It aims to help doctors make better decisions about your care.
Houston, TexasAges 20–50 - NCT07120958Enrolling by invitation
How uterine health affects embryo implantation
This trial studies how the immune system in the uterus may impact whether a genetically normal frozen embryo implants successfully. It aims to help improve success rates for women undergoing IVF.
Bisceglie, BTAges 20–42 - NCT07004192RecruitingPhase 4
hCG use in frozen embryo transfer
This study tests whether giving hCG before transferring a thawed embryo can improve success. It is for women who have at least one frozen embryo of good quality and are planning a frozen embryo transfer.
Las Vegas, NevadaAges 18 years+ - NCT06937645RecruitingPhase 2
Hyaluronic acid wash to improve pregnancy in IVF
This trial tests whether washing the uterus with hyaluronic acid before embryo transfer can improve pregnancy rates in women undergoing a fresh IVF cycle.
AL-Kadimya, Baghdad GovernorateAges 18–40 - NCT06896617RecruitingPhase 4
Corpus Luteum's effect on frozen embryo transfer pregnancies
This study looks at whether having a corpus luteum (the structure left after an egg is released) affects pregnancy outcomes in frozen embryo transfer cycles. It aims to help doctors choose the best way to prepare the body for embryo transfer.
Barcelona, SpainAges 18–41 - NCT06602687Recruiting
Does PICSI improve embryo health in older couples?
This study looks at whether a specific sperm selection method (PICSI) helps increase the number of chromosomally normal embryos in couples using ICSI and PGT-A. It may be especially relevant if you are an older couple or have concerns about sperm quality.
Dublin, DublinAges 35 years+ - NCT06524648Recruiting
Non-invasive embryo development check for frozen transfers
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
DoblAges 20–42 - NCT06513962RecruitingPhase 3
Triptorelin to protect ovaries in young women with cancer
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
Birmingham, AlabamaAges Up to 39 years - NCT07176689RecruitingPhase 4
Nirogacestat for desmoid tumors in premenopausal women
This trial tests a drug called nirogacestat to see if it can help premenopausal women with desmoid tumors (a type of non-cancerous growth) that are causing symptoms or getting worse. It aims to offer a new treatment option for those who need systemic therapy.
BrusselsAges 18–40
Hear when a new Infertile Females or Females With Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infertile females or females with ovarian insufficiency?
- Yes. Clin2 currently lists 166 recruiting infertile females or females with ovarian insufficiency studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infertile females or females with ovarian insufficiency trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infertile females or females with ovarian insufficiency trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.